BHOC VET-platform
Living veterinary evidence portal

Veterinary oxygen biology, evidence and source navigation.

A focused evidence map supporting BHOC Veterinary. Use this portal for guided context and developing Concepts & Questions, then continue into Vet Real-World Evidence & Cases for publications and regulatory records.

Regulatory and publication evidence

BHOC-platform Veterinary Regulatory & Science

Return to the Veterinary section for Oxyglobin regulatory records, FDA and EMA sources, and the indexed veterinary publication archive.

FDA primary evidence · Canine field trial

95% treatment success vs 32% control

Efficacy population: Oxyglobin 20/21 vs control 9/28; p≤0.001. Intent-to-treat: 73% (22/30) vs 29% (10/34).

FDA endpoint: no additional oxygen-carrying support required for 24 hours. This is a treatment-success endpoint, not survival.

Historical canine archive · Interpretation layer

From 885 reports to three research questions.

Oxyglobin Solution - Case Listing Book II is a manufacturer-collected descriptive archive, not a controlled efficacy trial. It contains 885 veterinary reports from 1998-1999 and 146 selected printed canine vignettes. Its recurring clinical pattern is oxygen-carrying support used as a bridge while definitive treatment addressed the cause.

885 reports146 printed vignettesDogs only3 anemia mechanisms
Question 1

When can oxygen support create time?

Define the window in which immediate oxygen-carrying support may bridge to hemorrhage control, surgery, disease-specific therapy, compatible blood or endogenous erythropoiesis.

Question 2

Which endpoints capture function?

PCV measures red-cell volume, not plasma hemoglobin. Total hemoglobin, circulation, unloading, tissue demand and clinical physiology must be considered together.

Question 3

What can translate beyond dogs?

Canine history can define research questions. It cannot establish formulation, dose, rate, safety, efficacy or approval in another species.

Evidence boundary: descriptive, product-specific and selection-prone. The archive is separate from the controlled FDA field trial and is not evidence of BHOC efficacy. The full scan is not republished while redistribution rights remain unconfirmed.

Evidence portal taxonomy

One entry point. Clear evidence boundaries.

Dog-specific approval

Oxyglobin regulatory evidence

Dog indication, FDA endpoint, product history and primary regulatory sources. Approval must not be transferred to other species or BHOC.

Translational

Feline evidence

Cat donor-blood constraints, case literature and clearly labelled off-label or translational oxygen-carrier evidence.

Species evidence

Equine medicine

Equine surgery, hemorrhage, transfusion logistics, oxygen physiology and species-specific safety questions.

Species evidence

Camelids

Camel and camelid oxygen biology, distinctive erythrocyte physiology and evidence gaps relevant to development.

Species evidence

Avian, raptor & parrot

Avian respiratory physiology and evidence requirements for birds, falcons, raptors and parrots.

Red Book Mission

Wildlife & conservation

Zoo, wildlife, marine and endangered-species care with independent biodiversity sources and no endorsement claims.

Evidence methods

Publications & safety

Publication taxonomy for efficacy, dosing, NO scavenging, vasoconstriction, methemoglobin, renal and immunologic safety.

Clinical context

Veterinary blood systems

Animal blood banks, donor availability, crossmatching, storage, wastage and the multifunctional role of donor blood.

Source-linked research

Oxyglobin & HBOC studies

Six directly relevant historical publications with original sources. The complete bibliography remains in the central BHOC catalogue.

Developing evidence base

BHOC development

BHOC means Biological Hemoglobin Oxygen Carrier. It is a developing product category with an emerging evidence base, not a transferred approval claim.

Research concepts

Concepts & Questions

Developing veterinary questions, hypotheses and pre-publication analysis kept separate from established evidence. First concept: donor welfare, feline blood donation and an additional oxygen-delivery layer.

Hemoglobin & other oxygen-carrying pigments

Nature uses more than one hemoglobin strategy.

Hemoglobin

Iron-containing heme protein and the central oxygen carrier across almost all vertebrate life.

Hemocyanin

Copper-based oxygen carrier found in many molluscs and arthropods.

Hemerythrin

Non-heme iron oxygen-binding protein found in several marine invertebrate groups.

Chlorocruorin

Greenish extracellular respiratory pigment found in certain marine polychaete worms.

Erythrocruorin

Large extracellular hemoglobin complex found in annelids and some other invertebrates.

Antarctic icefish

A notable vertebrate exception: adult crocodile icefish lack functional hemoglobin and rely on specialized cold-water physiology.

Nature Is a Great EngineerHeme and chlorophyll are built on closely related tetrapyrrole chemistry. Their molecular architecture follows the same fundamental biological design, but with a remarkable change at the center: Heme coordinates iron (Fe). Chlorophyll coordinates magnesium (Mg). Different metals. Related molecular architecture. Different functions.
The same extraordinary engineering logic of nature.
Evidence bridge

From established search history to a developing category.

Veterinary need→Oxyglobin→HBOC→BHOC→Biological Hemoglobin Oxygen Carrier→Precision Oxygen Therapeutics